213 related articles for article (PubMed ID: 28322154)
1. Mechanisms and Drug Targets for Pancreatic Cancer Chemoprevention.
Dhar D; Raina K; Agarwal R
Curr Med Chem; 2018; 25(22):2545-2565. PubMed ID: 28322154
[TBL] [Abstract][Full Text] [Related]
2. Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer.
Subramaniam D; Kaushik G; Dandawate P; Anant S
Curr Med Chem; 2018; 25(22):2585-2594. PubMed ID: 28137215
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells.
Barman S; Fatima I; Singh AB; Dhawan P
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946266
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of pancreatic cancer: a review of the molecular pathways involved, and evidence for the potential for chemoprevention.
Doucas H; Garcea G; Neal CP; Manson MM; Berry DP
Pancreatology; 2006; 6(5):429-39. PubMed ID: 16847380
[TBL] [Abstract][Full Text] [Related]
5. Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells.
Okuhashi Y; Itoh M; Nara N; Tohda S
Anticancer Res; 2011 Mar; 31(3):893-6. PubMed ID: 21498710
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention strategies for pancreatic cancer.
Stan SD; Singh SV; Brand RE
Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):347-56. PubMed ID: 20440279
[TBL] [Abstract][Full Text] [Related]
7. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
8. Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.
Baines AT; Martin PM; Rorie CJ
Prog Mol Biol Transl Sci; 2016; 144():277-320. PubMed ID: 27865460
[TBL] [Abstract][Full Text] [Related]
9. Targeting signal transduction in pancreatic cancer treatment.
Yeh JJ; Der CJ
Expert Opin Ther Targets; 2007 May; 11(5):673-94. PubMed ID: 17465725
[TBL] [Abstract][Full Text] [Related]
10. Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer.
Mohammed A; Janakiram NB; Madka V; Li M; Asch AS; Rao CV
Curr Med Chem; 2018; 25(22):2535-2544. PubMed ID: 28183260
[TBL] [Abstract][Full Text] [Related]
11. Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability.
Distler A; Lang V; Del Vecchio T; Huang J; Zhang Y; Beyer C; Lin NY; Palumbo-Zerr K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1264-8. PubMed ID: 24445254
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Hedgehog and Notch signaling pathways.
Weiss GJ
J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1820-1. PubMed ID: 22005544
[No Abstract] [Full Text] [Related]
13. Emerging pathways and future targets for the molecular therapy of pancreatic cancer.
Vaccaro V; Melisi D; Bria E; Cuppone F; Ciuffreda L; Pino MS; Gelibter A; Tortora G; Cognetti F; Milella M
Expert Opin Ther Targets; 2011 Oct; 15(10):1183-96. PubMed ID: 21819318
[TBL] [Abstract][Full Text] [Related]
14. Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast-induced drug resistance.
Wang L; Liu X; Zhou Q; Sui M; Lu Z; Zhou Z; Tang J; Miao Y; Zheng M; Wang W; Shen Y
Biomaterials; 2017 Nov; 144():105-118. PubMed ID: 28837958
[TBL] [Abstract][Full Text] [Related]
15. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
[TBL] [Abstract][Full Text] [Related]
16. Targeting Hedgehog signaling pathway: Paving the road for cancer therapy.
Salaritabar A; Berindan-Neagoe I; Darvish B; Hadjiakhoondi F; Manayi A; Devi KP; Barreca D; Orhan IE; Süntar I; Farooqi AA; Gulei D; Nabavi SF; Sureda A; Daglia M; Dehpour AR; Nabavi SM; Shirooie S
Pharmacol Res; 2019 Mar; 141():466-480. PubMed ID: 30639373
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
[TBL] [Abstract][Full Text] [Related]
18. Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
Weiss GJ
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S409-10. PubMed ID: 23160337
[No Abstract] [Full Text] [Related]
19. Exploring Signaling Pathways and Pancreatic Cancer Treatment Approaches Using Genetic Models.
Khader S; Thyagarajan A; Sahu RP
Mini Rev Med Chem; 2019; 19(14):1112-1125. PubMed ID: 30924420
[TBL] [Abstract][Full Text] [Related]
20. Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.
Mattheolabakis G; Papayannis I; Yang J; Vaeth BM; Wang R; Bandovic J; Ouyang N; Rigas B; Mackenzie GG
Cancer Prev Res (Phila); 2016 Jul; 9(7):624-34. PubMed ID: 27138793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
